This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.
This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
EURIPID provides data for OECD Report
/in News /by Bettina HeindlOn 14 February 2023 the Organisation for Economic Co-operation and Development (OECD) published a health working paper on “Exploring the feasibility of monitoring access to novel medicine“. The OECD undertook a pilot study in EU Member States that aimed to determine the utility and feasibility of routine, cross-national monitoring of access to medicines across multiple […]
Project collaboration agreement between EURIPID and WHO
/in News /by Bettina HeindlThe EURIPID (European Integrated Price Information Database) Collaboration and WHO Headquarters have signed a project collaboration agreement. The aim of the project is to improve the transparency of markets for medicines, vaccines, and other health products. For the duration of the project, the EURIPID collaboration will assist the WHO with knowledge development, standards setting, and […]
Webinar on Best practices in the public procurement of medicines
/in News /by Bettina HeindlPublic procurement of medicines (PPM) is highlighted in the European Commission’s (EC) “Pharmaceutical Strategy for Europe” as an area where actions can be taken to improve access to medicines for patients in the European Union (EU). Therefore the EC commissioned a “Study on Best Practices in the Public Procurement of Medicines”, which was recently published […]